Prime Medicine, Inc. - COMMON STOCK (PRME)

Historical Holders from Q4 2022 to Q3 2025

Symbol
PRME on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
174,282,170
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
92,347,242
Holdings value
$511,533,781
% of all portfolios
0%
Number of holders
163
Number of buys
114
Number of sells
-37
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prime Medicine, Inc. - COMMON STOCK (PRME)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund XII, L.P. 10.4% $80,853,607 18,587,036 Robert Nelsen 07 Aug 2025
GV 2019, L.P. 12.3% $91,756,239 16,562,498 Alphabet Holdings LLC 30 Sep 2025
T. Rowe Price Investment Management, Inc. 5.3% $51,172,731 9,236,955 T. Rowe Price Investment Management, Inc. 30 Sep 2025
FMR LLC 3.8% $37,294,150 6,731,796 FMR LLC 30 Sep 2025
Newpath Partners, L.P. 4.7% $9,769,086 6,105,679 Newpath Partners, L.P. 31 Dec 2024

Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 92,347,242 $511,533,781 +$186,777,668 $5.54 163
2025 Q2 58,654,950 $144,864,309 -$2,708,584 $2.47 118
2025 Q1 60,327,480 $120,048,763 -$9,144,075 $1.99 121
2024 Q4 64,302,617 $187,767,212 -$16,411,951 $2.92 128
2024 Q3 68,711,037 $265,862,243 -$1,687,770 $3.87 113
2024 Q2 68,888,470 $353,995,003 +$8,574,594 $5.14 119
2024 Q1 66,659,039 $466,578,147 +$125,445,462 $7 112
2023 Q4 48,691,116 $431,437,073 -$10,408,984 $8.86 102
2023 Q3 49,517,421 $472,282,828 +$28,502,950 $9.54 82
2023 Q2 46,131,758 $675,732,293 +$67,078,075 $14.65 77
2023 Q1 41,738,575 $512,085,492 +$2,897,210 $12.3 73
2022 Q4 41,322,385 $767,784,036 +$767,085,261 $18.58 65